Compare Unity Software Inc (U) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Unity Software Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Unity Software Inc trades at $43.69 (market cap $19.31B), while State Street SPDR S&P Biotech ETF trades at $159.71. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Unity Software Inc nearer its low. Which is the better fit depends on your goals.
| U | XBI | |
|---|---|---|
Market Cap | $19.31B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $49.47 | $164.28 |
52-Week Low | $17.13 | $86.92 |
Enterprise Value | $19.19B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Unity Software (U) trades at $43.10, up 0.23% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $47.45. Recent Q2 2026 earnings beat expectations, with revenue growth of 24% year-over-year, driven by strong Vector advertising platform performance. The company reported positive operating cash flow of $422.96 million in 2025, though net income remains negative at -$402.77 million.
The outlook is mixed: strong revenue growth and analyst optimism support upside potential, but persistent net losses and high valuation ratios (P/S 9.33, EV/EBITDA 134.62) pose risks. Investors should weigh the company's path to GAAP profitability against competitive pressures in the software sector.
XBI trades at $159.15, up 0.71% with a bullish technical signal from moving averages. The biotech ETF shows strong momentum with a 17% monthly gain, driven by positive clinical data and M&A activity. Analyst coverage remains limited with a single hold rating, while institutional interest grows with recent $793,000 investment from Bay Colony Advisors.
Outlook remains positive given biotech sector resurgence, though elevated RSI suggests near-term overbought conditions. Key risks include sector volatility and regulatory uncertainty, but AI-driven drug discovery and strong pipeline developments provide growth catalysts for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Unity Software Inc
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.
Read more on U →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
